Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

Lorusso, V; Crucitta, E; Panza, N; Silvestris, N; Guida, M; Carpagnano, F; Mancarella, S; Sambiasi, D; De Lena, M

Lorusso, V; Crucitta, E; Panza, N; Silvestris, N; Guida, M; Carpagnano, F; Mancarella, S; Sambiasi, D; De Lena, M.

Affiliation

Lorusso V; Operative Unit of Medical Oncology, Oncology Institute of Bari, Italy. vitolorusso@inwind.it

Ann Oncol ; 13(12): 1862-7, 2002 Dec.

Article in En | MEDLINE | ID: mdl-12453853

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carcinoma, Non-Small-Cell Lung/drug therapy; Deoxycytidine/analogs & derivatives; Lung Neoplasms/drug therapy; Maximum Tolerated Dose; Vinblastine/analogs & derivatives; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung/mortality; Carcinoma, Non-Small-Cell Lung/pathology; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms/mortality; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Staging; Paclitaxel/administration & dosage; Paclitaxel/adverse effects; Risk Assessment; Survival Analysis; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/adverse effects; Vinorelbine; Gemcitabine

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Vinblastine / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Maximum Tolerated Dose / Deoxycytidine / Lung Neoplasms Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2002 Type: Article

Search on Google

XML

PubMed Links